SCHEMBL25663173

SCHEMBL25663173

c1cnc2ccc(-c3ccc(N(c4ccc(-c5ccc6ncccc6c5)cc4)c4ccc(-c5nccc6sc7ccccc7c56)cc4)cc3)cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ DYRK1A Q13627 1/20 0.40
▸ ADORA2A P29274 2/20 0.36
▸ GRM4 Q14833 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ GSK3B P49841 1/20 0.35
▸ PIK3CD O00329 2/20 0.34
▸ PIK3CA P42336 2/20 0.34
▸ PIK3CB P42338 2/20 0.34
▸ MTOR P42345 2/20 0.34
▸ PIK3CG P48736 2/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ CYP3A4 P08684 2/20 0.33
▸ GRM1 Q13255 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ HCK P08631 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663174 0.93 NPC1 (0.36) NPC1POLBRAB9ADYRK1AADORA2A
SCHEMBL25663176 0.91 NPC1 (0.36) NPC1POLBRAB9ADYRK1AGSK3B
SCHEMBL25663171 0.89 PDGFRB (0.44) DYRK1APIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663493 0.89 TGFBR1 (0.34) NPC1POLBRAB9APIK3CA
SCHEMBL24055540 0.88 HTR2B (0.40) NPC1RAB9AADORA2APIK3CDPIK3CA
SCHEMBL25714763 0.85 HTR2B (0.38) HTR2BHTR5A
SCHEMBL25663102 0.85 NPC1 (0.44) NPC1POLBRAB9ADYRK1AADORA2A
SCHEMBL24055851 0.85 TDO2 (0.38) NPC1RAB9AADORA2ACYP3A4HTR2B
SCHEMBL25663177 0.85 HTR2B (0.33) HTR2BHTR5A
SCHEMBL26834745 0.84 HTR2B (0.37) HTR2BHTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 NPC1 3859/4885POLB 4099/4885RAB9A 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback